Zimmer Biomet Holdings, Inc. logo
Zimmer Biomet Holdings, Inc. (ZBH)
Compare

Zimmer Biomet Holdings, Inc. (ZBH) Net Profit Margin: 9.05%

Is Zimmer Biomet Holdings, Inc.’s net profit margin high or low?

Zimmer Biomet Holdings, Inc.'s net profit margin of 9.05% is 32% above its 5-year average of 6.86%, near the high end of its 5-year range (-2.27%–13.85%).

As of Saturday, June 20, 2026. 11.01% below its 12-month average of 10.17%.

ZBH Net Profit Margin Chart

ZBH Net Profit Margin
8.57%-27.19% 1Y
Zoom

ZBH Average Net Profit Margin Chart

ZBH Current vs Average Net Profit Margin Chart

ZBH Net Profit Margin Metrics

NET PROFIT MARGIN

9.05%

NET PROFIT MARGIN AVG TTM

10.17%

NET PROFIT MARGIN AVG 3Y

9.38%

NET PROFIT MARGIN AVG 5Y

6.86%

NET PROFIT MARGIN AVG 10Y

7.29%

NET PROFIT MARGIN AVG 15Y

10.01%

NET PROFIT MARGIN AVG 20Y

12.59%

CURRENT VS TTM AVG

-11.01%

CURRENT VS 3Y AVG

-3.52%

CURRENT VS 5Y AVG

+32.02%

CURRENT VS 10Y AVG

+24.11%

CURRENT VS 15Y AVG

-9.61%

CURRENT VS 20Y AVG

-28.09%

ZBH Competitors' Net Profit Margin

NAMEMARKET CAPNET PROFIT MARGINTTM3Y5Y
Zimmer Biomet Holdings, Inc. (ZBH)$17.02B9.05%10.17%9.38%6.86%
Hologic, Inc. (HOLX)vs ›$16.97B13.18%16.70%17.87%22.37%
DaVita Inc. (DVA)vs ›$13.34B5.65%6.39%5.83%6.41%
Medpace Holdings, Inc. (MEDP)vs ›$13.14B17.19%18.50%17.20%16.74%
Solventum Corporation (SOLV)vs ›$13.06B17.33%12.25%14.36%15.15%
Labcorp Holdings Inc. (LH)vs ›$20.98B6.66%6.01%6.56%9.24%
Align Technology, Inc. (ALGN)vs ›$13.04B10.50%10.36%10.48%22.21%
The Cooper Companies, Inc. (COO)vs ›$12.85B5.57%9.62%9.77%24.94%
United Therapeutics Corporation (UTHR)vs ›$22.78B40.61%41.73%40.84%37.71%
Revvity, Inc. (RVTY)vs ›$11.16B8.30%9.60%8.02%12.66%

Margin Comparison

Operating Margin

15.6%

Net Profit Margin

9.1%

Zimmer Biomet Holdings, Inc. Net Profit Margin Formula & Definition

Net Profit Margin = Net Income / Revenue

Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Zimmer Biomet Holdings, Inc. Net Profit Margin FAQ

What is the net profit margin for Zimmer Biomet Holdings, Inc. (ZBH)?
The net profit margin for ZBH stock is 9.05%.
Is Zimmer Biomet Holdings, Inc.'s net profit margin high or low?
Zimmer Biomet Holdings, Inc.'s net profit margin of 9.05% is 32% above its 5-year average of 6.86%, near the high end of its 5-year range (-2.27%–13.85%).
What is the TTM average net profit margin for Zimmer Biomet Holdings, Inc. (ZBH)?
The TTM average net profit margin for ZBH stock is 10.17%.
What is the 3Y average net profit margin for Zimmer Biomet Holdings, Inc. (ZBH)?
The 3Y average net profit margin for ZBH stock is 9.38%.
What is the 5Y average net profit margin for Zimmer Biomet Holdings, Inc. (ZBH)?
The 5Y average net profit margin for ZBH stock is 6.86%.
What is the 10Y average net profit margin for Zimmer Biomet Holdings, Inc. (ZBH)?
The 10Y average net profit margin for ZBH stock is 7.29%.
What is the 15Y average net profit margin for Zimmer Biomet Holdings, Inc. (ZBH)?
The 15Y average net profit margin for ZBH stock is 10.01%.
What is the 20Y average net profit margin for Zimmer Biomet Holdings, Inc. (ZBH)?
The 20Y average net profit margin for ZBH stock is 12.59%.

Zimmer Biomet Holdings, Inc. Net Profit Margin History

DATENET PROFIT MARGIN
2025-12-318.57%
2024-12-3111.77%
2023-12-3113.85%
2022-12-313.33%
2021-12-315.88%
2020-12-31-2.27%
2019-12-3114.18%
2018-12-31-4.78%
2017-12-3123.24%
2016-12-313.99%
2015-12-312.45%
2014-12-3115.41%
2013-12-3116.46%
2012-12-3116.88%
2011-12-3117.09%
2010-12-3114.14%
2009-12-3117.52%
2008-12-3120.59%
2007-12-3119.84%
2006-12-3123.87%
2005-12-3122.29%
2004-12-3118.18%
2003-12-3118.22%
2002-12-3118.78%
2001-12-3112.71%
2000-12-3116.91%
1999-12-3115.97%
1998-12-3116.84%

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. (ZBH), along with its global subsidiaries, operates as a leading player in the musculoskeletal healthcare sector. The company extends its reach across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. ZBH is responsible for the design, manufacturing, and marketing of a wide array of orthopedic reconstructive solutions, including prominent knee and hip replacement systems. Their offerings also encompass Specialized Enabling Technologies (S.E.T.) products, which cover areas such as sports medicine, biologics, foot and ankle care, extremity treatments, and trauma management. Furthermore, the company provides medical devices and surgical instruments specifically for spinal conditions, alongside products for facial and cranial reconstruction. A unique part of their portfolio includes systems designed to stabilize and fixate chest bones, facilitating recovery or reconstruction following open-heart surgery, traumatic injuries, or congenital chest deformities. The company's product lines also feature a comprehensive range of dental solutions, such as reconstructive implants, prosthetics, and regenerative materials. Additionally, they are involved in robotic surgical systems, general surgical instruments, and bone cements. These advanced products and solutions are primarily utilized to address conditions in patients suffering from disorders or injuries affecting bones, joints, and their associated soft tissues. Zimmer Biomet caters to a broad clientele, including orthopedic, neuro-, and oral surgeons, dentists, hospitals, independent distributors, healthcare suppliers, and various other medical specialists. Their network further encompasses agents, healthcare purchasing organizations, and group buying alliances. Originally established in 1927, the enterprise was initially known as Zimmer Holdings, Inc., before rebranding as Zimmer Biomet Holdings, Inc. in June 2015. Its corporate headquarters are situated in Warsaw, Indiana.

Warsaw, IN
17,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Ivan Tornos